Febuxostat Formyl Hydroxy Ethyl Ester CAS 161798-03-4 Pite > 99.0% (HPLC) Febuxostat Entèmedyè Faktori

Deskripsyon kout:

Non Chimik: Ethyl 2-(3-Formyl-4-Isobutoxyphenyl)-4-Methylthiazole-5-Carboxylate

Sinonim: Febuxostat Formyl Hydroxy Ethyl Ester

CAS: 161798-03-4

Pite:> 99.0% (HPLC)

Aparans: Limyè jòn jòn poud oswa kristal

Entèmedyè Febuxostat (CAS: 144060-53-7)

E-Mail: alvin@ruifuchem.com

Voye imèl ba nou

Pwodwi detay

Pwodwi ki gen rapò

Tags pwodwi

Deskripsyon:

Ruifu Chemical Supply Febuxostat Entèmedyè ki gen rapò:
Febuxostat CAS 144060-53-7
Ethyl 2-Chloroacetoacetate CAS 609-15-4
4-Hydroxythiobenzamide CAS 25984-63-8
Etil 2-(3-Cyano-4-Hydroxyphenyl)-4-Methyl-1,3-Thiazole-5-Carboxylate CAS 161798-02-3
Ethyl 2-(3-Cyano-4-Isobutoxyphenyl) -4-Methyl-5-Thiazolecarboxylate CAS 160844-75-7
Ethyl 2-(3-Formil-4-Hydroxyphenyl) -4-Methylthiazole-5-Carboxylate CAS 161798-01-2
Ethyl 2-(3-Formil-4-Isobutoxyphenyl) -4-Methylthiazole-5-Carboxylate CAS 161798-03-4
Ethyl 2-(4-Hydroxyphenyl)-4-Methylthiazole-5-carboxylate CAS 161797-99-5

Pwopriyete chimik:

Non Chimik	Etil 2-(3-formyl-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate
Sinonim	Febuxostat Formyl Hydroxy Ethyl Ester;Febuxostat enpurte 2;Febuxostat Entèmedyè 4
Nimewo CAS	161798-03-4
Nimewo CAT	RF-PI1856
Estati Stock	Nan Stock, Pwodiksyon Echèl Jiska Tòn
Fòmil molekilè	C18H21NO4S
Pwa molekilè	347,43
Dansite	1.183
Mak	Ruifu Chimik

Espesifikasyon:

Atik	Espesifikasyon
Aparans	Limyè jòn jòn poud oswa kristal
Pite / Metòd analiz	>99.0% (HPLC)
Kontni dlo (KF)	<0.50%
Rezid sou ignisyon	<0.50%
Enpurte total	<1.00%
Spectre 1H RMN	Ki konsistan avèk estrikti
Tès Creole	Enterprise Standard
Itilizasyon	Entèmedyè Febuxostat (CAS: 144060-53-7)

Pake & Depo:

Pake: Boutèy, sak papye aliminyòm, 25kg / tanbou katon, oswa selon kondisyon kliyan an

Kondisyon Depo:Sere nan resipyan ki fèmen nan yon kote ki fre ak sèk;Pwoteje kont limyè ak imidite

Avantaj:

FAQ:

Aplikasyon:

Ethyl 2-(3-Formyl-4-Isobutoxyphenyl)-4-Methylthiazole-5-Carboxylate (CAS: 161798-03-4) se yon entèmedyè oswa enpurte Febuxostat (CAS: 144060-53-7).Febuxostat se yon nouvo jenerasyon xanthine inibitè oksidaz devlope pa Tejin Co. (Japon,) itilize klinikman pou tretman alontèm nan hyperuicemia (gout,) yon nouvo ak trè efikas ki pa purine inibitè selektif nan xanthine oksidaz.Li pa rekòmande pou pasyan gout san ipèrisemi.